Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Recombinant human lysosomal acid lipase

EU orphan designation number: EU/3/10/827   
Active ingredient: Recombinant human lysosomal acid lipase
Indication: Treatment of lysosomal acid lipase deficiency
Sponsor: Synageva BioPharma Ltd
1A Local Board Road, Watford, Hertfordshire WD 17 2JP, United Kingdom
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name Kanuma on with the number EU/1/15/1033

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/12/2010 Orphan Designation EMA/OD/104/10 (2010)9540 of 17/12/2010
02/09/2011 Transfer of orphan designation EMA/OD/104/10/T/01 (2011)6292 of 30/08/2011
14/11/2014 Change of address of sponsor